MEMORANDUM AND ORDER RE: INVENTORSHIP, OBVIOUSNESS, INEOUTABLE CONDUCT
SHUBB, District Judge.
In a separate order, the court has determined that Genentech's product, Herceptin, infringes Chiron's U.S. Patent No. 6,054,561 ("'561 patent"). Genentech has asserted a number of defenses and counterclaims, three of which—invalidity for failure to join a co-inventor of the patent, invalidity for obviousness, and inequitable conduct—concern...
Let's get started

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.